Trial NCT05422794

View at ClinicalTrials.gov 
Org. Study IDs: NCI-2022-04956
Secondary IDs: 10525 DFHCC #22-589 NCI-2022-04956 UM1CA186709

Last trial update was posted on 2024-04-17

MeSH Interventions

Albumin-Bound Paclitaxel Paclitaxel Pembrolizumab

MeSH Conditions

Breast Neoplasms Carcinoma Triple Negative Breast Neoplasms

Other Conditions

Anatomic Stage III Breast Cancer AJCC v8 Anatomic Stage IV Breast Cancer AJCC v8 Locally Advanced Triple-Negative Breast Carcinoma Metastatic Triple-Negative Breast Carcinoma Unresectable Triple-Negative Breast Carcinoma

Stopping Reasons

Other - DLT evaluation and analysis.

Limitations And Caveats

N/A

Result Publications

N/A

Annotations

Category Annotations
No annotators decided on categories yet

Intervention Annotations
# Outdated Intervention Condition
Name Route DrugBank ID